Serum Albumin and C3 Complement Levels in Endometriosis

Hasan, Aisha and Rahim, Amena and Afzal, Muhammad and Naveed, Abdul khaliq and Ayub, Saddaf and Jahan, Saira (2019) Serum Albumin and C3 Complement Levels in Endometriosis. JCPSP, 29 (8). pp. 702-705.

Full text not available from this repository.

Abstract

Objective: To compare the efficacy of albumin and C3 complement as serum marker for the early diagnosis of
endometriosis in women of reproductive age.
Study Design: Cross-sectional comparative study.
Place and Duration of Study: Biochemistry Department, Islamic International Medical College, Rawalpindi, in collaboration
with the Gynecology and Obstetrics Department, Pakistan Railways Hospital, Rawalpindi, from March 2017 to February
2018.
Methodology: Forty-four patients with endometriosis and 44 controls of reproductive age group were enrolled for the
study. Those having other comorbid systemic or endocrine diseases were excluded from the study. Levels of albumin and
C3 complement were measured by using Micro Lab 300 and ELISA, respectively; and the results were compared by using
SPSS version 21.
Results: The mean serum albumin levels were 4.62 ±0.88 g/dl and 4.42 ±0.52 g/dl in the control and endometriosis
groups, respectively (p=0.201). The mean serum C3 levels were 1120.9 ±265 μg/ml and 2241.0 ±293 μg/ml in the control
and endometriosis patient groups, respectively (p <0.001).
Conclusion: Serum C3 complement were significantly increased in endometriosis patients but not in controls; whereas,
serum albumin levels were not significantly different in endometriosis cases as compared to the controls.

Item Type: Article
Subjects: R Medicine > R Medicine (General)
R Medicine > RZ Other systems of medicine
Divisions: Faculty of Rehabilitation and Allied Health Sciences(FRAHS) > Riphah College of Rehabiliation and Allied Sciences Islamabad
Depositing User: Dr Saira Jahan
Date Deposited: 05 May 2020 07:09
Last Modified: 05 May 2020 07:09
URI: http://research.riphah.edu.pk/id/eprint/457

Actions (login required)

View Item View Item